Frequently Asked
Questions

HTB is a platform technology company developing innovative analytical technologies for research, diagnostics, public health, and molecular authentication.

HTB combines proprietary platform technologies, scientific expertise, small-business agility, and federally supported research experience.

HTB works with government agencies, academic laboratories, industry partners, and research collaborators.

BLISA™ is HTB’s proprietary Bead-Linked Immunosorbent Assay platform for rapid, quantitative, highly multiplexed immunoassays.

BLISA is designed for rapid workflows, quantitative results, high multiplexing, low sample volume, specificity, and automation-ready development.

BLISA is designed for a broad range of analytical targets, including biomarkers, proteins, peptides, cytokines, small molecules, and related research analytes.

Please contact HTB to discuss current platform status, collaborations, and application-specific opportunities.

HTB offers multiplex immunoassays, assay development, biomarker analysis, microfluidics and automation, image and data analysis, and custom platform development.

HTB may collaborate on application-specific assay development. Contact us to discuss your scientific goals.

Yes. HTB has federal R&D experience, including NIH SBIR funding and government-supported innovation programs.

HelixShield is HTB’s molecular authentication and information protection platform for verifying high-value materials and sensitive information.

HTB is located in Summit, New Jersey, USA.

Use the Contact page or email contact@htbiology.com.